![Medicare Expands Coverage of Molecular Cancer Screening Tests](https://www.g2intelligence.com/wp-content/uploads/2023/05/May23.LIR_.MedicareGeneticTestCoverage-iStock-1169304873-1100x800-1-1080x675.jpg)
Medicare Expands Coverage of Molecular Cancer Screening Tests
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.
Recently released AACC document covers newly updated screening guidelines as well as information on surveillance and diagnosis.